Zambon is a multinational pharmaceutical and chemical company that focuses on innovation and development with the aim to improve the quality of people’s health and patients’ lives. Based on a valuable heritage but strongly focused on the future, its Vision is “Innovating cure and care to make patients’ lives better”.
Zambon operates in the pharmaceutical and chemical business and is present in 20 countries with subsidiaries in three different Continents – Europe, America and Asia – and almost 2800 employees, with manufacturing units in Italy, Switzerland, France, China and Brazil. Zambon products are commercialized in 84 countries.
The company is currently pursuing a new challenge, working on the treatment of specialties and rare diseases, such as Parkinson’s disease and Cystic Fibrosis and is well-established in 3 therapeutic areas: respiratory, pain and women’s care.
Zambon produces high quality products thanks to the management of the whole production chain which involves Zach (Zambon chemical), a privileged partner for API, custom synthesis and generic products.
Recognizing the ever-growing importance of innovative technologies and the digitalization of healthcare, Zambon complements the offering of medicines with modern health solutions, in order to translate its Vision into concrete actions.
Zcube - Zambon Research Venture - is actively scouting for modern health solutions in the field of drug delivery systems, medical devices, biomarkers, diagnostics, digital health and big data solutions.
Zambon was established in 1906 in Vicenza and is headquartered in Milan within OpenZone, a scientific campus founded with the aim to create an entrepreneurial ecosystem where the knowledge is shared between partners in the field of Life Sciences.
